After Hours
|
||||
|
|
|
|
Regular Hours (Closed)
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-2.26/-17.42
|
|
Enterprise Value
1.04M
|
| Balance Sheet |
|
Book Value Per Share
0.32
|
| Cash Flow |
|
Cash Flow Yield
--
|
| Income Statement |
|
Total Revenue
449.62K
|
|
Operating Revenue Per Share
--
|
|
Industry Comparison
|
||||||||||||||||
|
||||||||||||||||
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft. |

-- 

0.182